从事眼科临床、科研和教学工作20余年，曾留学美国洛杉矶 UCLA大学附属Doheny眼科研究所和澳大利亚多年，完成博士后深造。擅长玻璃体视网膜疾病和白内障的诊治，尤其擅长眼底黄斑疾病、糖尿病性视网膜病变、眼底血管阻塞性疾病和视神经疾病的诊治；熟练运用眼科激光技术、玻璃体内药物注射技术及手术方法治愈上万例眼底疾病患者。主持并完成多项科研项目包括国家自然基金面上项目、市科委及卫健委项目等，已发表SCI学术论文50余篇，培养研究生近20名。以下为近几年发表的主要SCI文章和科研项目：
Bai J, Wan Z, Zhang Y, Wang T, Xue Y, Peng Q*. Composition and diversity of gut microbiota in diabetic retinopathy[J]. Frontiers in Microbiology. 2022; 13: 926926.
Tingting Sun，Jianhao Bai，Minli Wang，Peng Gao，Le Liu，Qing Peng*. Cytokine Profiling in Patients with Polypoidal Choroidal Vasculopathy Before and After Intravitreal Injection of Ranibizumab[J]. Am J Transl Res. 2022, on line
Tianyu Wang, Tong Zhu, Yuanyuan Zhang, Jianhao Bai, Yawen Xue, Guotong Xu, Lixia Lu, Qing Peng*. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe? [J]. Gene. 2022; 840: 146765.
Tianyu Wang†, Jianhao Bai†, Yuanyuan Zhang, Yawen Xue, Qing Peng*. N6-Methyladenosine regulator. RBM15B acts as an independent prognostic biomarker and its clinical significance in uveal melanoma[J]. Frontiers in Immunology. 2022; 918522
Tingting Sun，Qingquan Wei，Peng Gao，Yongjie Zhang，Qing Peng*. Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization[J]. Drug Design, Development and Therapy[J]. 2021; 15: 2457–2467
Yaoyan Qiu, Tingting Sun, Feijia Xu, Peng Gao*, Guangyu Tang*, Qing Peng*. Correlation of vascular change and cognitive impairment in age-related macular degeneration patients[J]. Am J Transl Res. 2021; 13(1):336-348
Tianyu Wang, Yuanyuan Zhang, Jianhao Bai, Yawen Xue, Qing Peng*. MMP1 and MMP9 are potential prognostic biomarkers and targets for uveal melanoma[J]. BMC Cancer. 2021; 21:1068
Qingquan Wei，Zhongqi Wan，Yongcheng Hu，Qing Peng*. Cytokine and Chemokine Profile Changes in Patients After Intravitreal Conbercept Injection for Diabetic Macular Edema[J]. Drug Design, Development and Therapy. 2019, 13: 4367-4374
Qingquan Wei, Tingting Sun, Zhongqi Wan, Yongjie Zhang, Qing Peng*. Cytokine and chemokine profile changes in patients after intravitreal conbercept injection for center macular edema due to branch retinal vein occlusion[J]. Am J Transl Res. 2020;12(7):4001-4008
Tingting Sun, Zhongqi Wan, Yan Gao, Li Zhang, Qing Peng*. Fundus imaging features of massive hemorrhaging in polypoidal choroidal vasculopathy after treatment. Int J Clin Exp Med. 2020; 13(8): 5736-5744
Yinghua Fu, Yao Wang, Yin Zhong, Dongxiang Fu, Qing Peng*. Change detection based on tensor RPCA for longitudinal retinal fundus images[J]. Neurocomputing, 2020; 387:1-12
12. Wang TY, Wan ZQ, Peng Q*. A patient misdiagnosed with central serous chorioretinopathy: A case report[J]. World Journal of Clinical Cases. 2019; 7(16), 2341-2345
13. Kaijie Ma, Le Liu, Pengfei Zhang, Yonghong He, Qing Peng*. Optimization of angle-pixel resolution for angular plasmonic biosensors[J]. Sensors and Actuators B: Chemical. 2019; 283:188-197
14. Qing Peng#, Yutong Chen, Rui Hua. The modification of fluorescein angiography and its application in age-related macular degeneration and polypoidal choroidal vasculopathy[J]. Ophthalmic Research 2018,7:1-4
15. Yinghua Fu, Chongyang Wang, Yao Wang, Benzhi Chen, Qing Peng* and Lisheng Wang*. Automatic detection of longitudinal changes for retinal fundus images based on low-rank decomposition[J]. Journal of Medical Imaging and Health Informatics. 2018; 8(2), 284-294
科研项目（以下均为项目负责人）
1. 主持上海市科委项目1项（在研）：题目：“科学-城市-生活”系列科普活动——眼底疾病防治。经费：20万，项目编号：22DZ2300200，时间：2022-8至2023年
2. 主持并完成国家自然基金面上项目1项：题目“基于SPR技术研究房水中靶因子在新生血管AMD疾病中的致病机理”，项目编号：81470025， 30万
3. 主持一项申康科研项目（在研）。题目：《促进市级医院临床技能与临床创新三年行动计划》关键支撑项目，2020-2022年，经费：50万， 项目编号：SHDC2020CR5014
4. 主持4项厅局级和院级项目：
(1) 上海市卫健委：“视神经萎缩性疾病的中西医结合临床体系研究”
编号：No. ZY（2018-2020)--FWTX-3010
(2) 上海市卫健委：“糖尿病视神经网膜病变的中西医结合治疗”
编号：No. ZY (2018-2020)-ZWB-1001-CPJS10
(3) 上海市卫健委重点学科经费：CBA技术检测黄斑变性（AMD）患者房水中细胞因子表达
(4) 十院引进人才科研经费：CNV患者房水中靶因子的变化与疾病发病机制的相关性
5. 作为项目负责人（PI）负责4项全球药物临床试验（GCP）项目，作为Sub-I负责1项GCP项目，所有项目进展顺利。
